She is currently working on several protocols including HIV Prevention Trial Network (HPTN) 084 and 081, HIV Vaccine Trials Network (HVTN) 705, IMPAACT 2008, P1115, 2016, Adult Clinical Trials Group (ACTG) 5354, 5375, 5381, and most recently the COVID-19 protocol, COVPN 405.
She also has experience working as Clinical Research Site (CRS) Coordinator for the Soweto-Kliptown (South Africa) HIV Vaccine Trials Network (HVTN) CRS where she oversaw operations of clinic activities on the HVTN 702, HVTN 705 and HVTN 108 clinical trials. As senior data manager at the Wits Reproductive Health and HIV Institute (WRHI) in Johannesburg, she optimized efficiencies in the data department resulting in improved data submission timelines and data services to the clinic. She also oversaw quality control and quality assurance processes as internal monitor at the Soweto-Kliptown CRS prior to her appointment as CRS coordinator where she guided the relatively research-naïve team at that time in the ethical and accurate implementation and conduct of clinical trials. In collaboration with Dr. Erica Lazarus who was also her mentor, she implemented various systems and strategies to optimize clinic flow and quality resulting in their site being in the top five for data quality and timeliness as well as participant retention.
Before migrating to South Africa, she had worked as a study coordinator of HPTN 052 at the Malawi CRS before her appointment as co-Investigator of the “A Study to Prevent Infection with a Ring for Extended Use” (ASPIRE) microbicide study evaluating a dapivirine vaginal ring for long-acting pre- exposure prophylaxis of HIV. She proved her ability to oversee appropriate recruitment of high risk participants evidenced by high incidence of sexually transmitted infections including an HIV incidence rate greater than 4/100py.
In the early years of her career, she was a physician assistant in the Surgical, Medicine, Pediatrics, and Obstetrics and gynecological departments in a provincial hospital in Malawi.
